Acute Myeloid Leukemia Therapy
Findings from German Cancer Research Center advance knowledge in acute myeloid leukemia therapy
Published in Disease Risk Factor Week, June 1st, 2008
Research findings, 'Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups,' are discussed in a new report. According to recent research from Heidelberg, Germany, "Drug metabolism/disposition and transporter genes may influence predisposition or prognosis of AML (acute myeloid leukemia) patients. We analyzed polymorphisms in 3 transporters and 4 drug metabolism genes in 293 Israeli individuals (112 AML patients and 181 controls)."
"We analyzed: ABCC3 (MRP3) C-211T; ABCG2 (BCRP) C421A; CNT1 (SLC28A1) G565A and NAT1, NAT2, and GSTT1 and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
More Articles from Disease Risk Factor Week
- Acid Reflux Disease
New acid reflux disease study findings have been reported by scientists at University Hospital - Acid Reflux Disease
Research from H. Nordenstedt and colleagues provide new insights into acid reflux disease - Addiction Medicine
New addiction medicine study findings have been reported by A. Merline and colleagues - Adenocarcinoma Epidemiology
Research from Royal Free and University College reveals new findings on adenocarcinoma epidemiology - Agranulocytosis Animal Studies
Research from University of Toronto, Leslie Dan Faculty of Pharmacy broadens understanding of agranulocytosis animal studies - Alcoholism
Investigators at National Institutes of Health zero in on alcoholism - More from this issue of Disease Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
